Whole Exome Sequencing Analysis of Good and Bad Prognostic Neuroblastoma Patients (on the Behalf of Turkish Pediatric Oncology Group) †
Abstract
:1. Introduction
2. Material and Methods
3. Results
4. Discussion
5. Conclusions
Acknowledgments
References
- Pizzo, P.; Poplack, D.G. Principles and Practice of Pediatric Oncology, 7th ed.; Wolters Kluver: Philadelphia, PA, USA, 2016. [Google Scholar]
- Aksoylar, S.; Varan, A.; Vergin, C.; Hazar, V.; Akici, F.; Dagdemir, A.; Buyukavci, M.; Kebudi, R.; Kurucu, N.; Sevinir, B.; et al. Treatment of high-risk neuroblastoma: National protocol results of the Turkish Pediatric Oncology Group. J. Cancer Res. Ther. 2017, 13, 284–290. [Google Scholar] [PubMed]
- Tonini, G.P. Growth, progression and chromosome instability of Neuroblastoma: A new scenario of tumorigenesis. BMC Cancer 2017, 17, 20. [Google Scholar] [CrossRef]
- Chan, H.S.; Gallie, B.L.; Deboer, G.; Haddad, G.; Ikegaki, N.; Dimitroulakos, J.; Yeger, H.; Ling, V. MYCN protein expression as a predictor of neuroblastoma prognosis. Clin. Cancer Res. 1997, 3, 1699–1706. [Google Scholar]
- Bown, N. Neuroblastoma tumour genetics: Clinical and biological aspects. J. Clin. Pathol. 2001, 54, 897–910. [Google Scholar] [CrossRef] [PubMed]
- Shyr, S.; Liu, Q. Next generation sequencing in cancer research and clinical application. Biol. Proc. Online 2013, 15, 4. [Google Scholar] [CrossRef] [PubMed]
- Kamps, R.; Brandao, R.D.; van den Bosh, B.; Paulussen, A.D.; Xanthoulea, S.; Blok, M.J.; Romano, A. Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification. Int. J. Mol. Sci. 2017, 18, 308. [Google Scholar] [CrossRef] [PubMed]
- TPOG. Turkish Society of Pediatric Oncology Group (TPOG). Neuroblastoma—2009 Treatment Protocol; National Cancer Congress-2009, TURKEY; 2009. [Google Scholar]
NB Code | Gender | Age (Month) | Primer | Nmyc amp | 1p LOH | 11q Del | 17q Gain | DNA Ploidy | Stage | Histology |
---|---|---|---|---|---|---|---|---|---|---|
High Prognostic Group (Intermediate Poor Histology–High Risk Group) | ||||||||||
NB26 | Female | 66 | Subrenal | - | + | + | + | =1 | IV | Poor |
NB27 | Male | 144 | Paraspinal | - | - | + | - | =1 | III | poor |
NB39 | Female | 9 | Pelvic | - | - | - | - | <1 | IV | Poor |
NB44 | Female | 84 | Subrenal | - | + | - | + | <1 | IV | Poor |
NB78 | female | 84 | Undefined | - | - | - | + | <1 | IV | Poor |
Low Prognostic Group (Low or Intermediate Good Histology) | ||||||||||
NB41 | Female | 7 | Paraspinal | - | - | - | - | <1 | I | Good |
NB144 | Male | 14 | Paraspinal | - | + | + | - | =1 | I | Good |
NB145 | Female | 14 | Servical | - | + | + | - | <1 | IIB | Poor |
NB154 | Male | 60 | Abdominal | - | - | - | - | =1 | I | Poor |
NB183 | Male | 42 | Trokal | - | - | + | + | 1 | I | Good |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Altun, Z.; Baran, B.; Aktaş, S.; Yuan, H.; Olgun, N. Whole Exome Sequencing Analysis of Good and Bad Prognostic Neuroblastoma Patients (on the Behalf of Turkish Pediatric Oncology Group). Proceedings 2018, 2, 1530. https://doi.org/10.3390/proceedings2251530
Altun Z, Baran B, Aktaş S, Yuan H, Olgun N. Whole Exome Sequencing Analysis of Good and Bad Prognostic Neuroblastoma Patients (on the Behalf of Turkish Pediatric Oncology Group). Proceedings. 2018; 2(25):1530. https://doi.org/10.3390/proceedings2251530
Chicago/Turabian StyleAltun, Zekiye, Burçin Baran, Safiye Aktaş, HongLing Yuan, and Nur Olgun. 2018. "Whole Exome Sequencing Analysis of Good and Bad Prognostic Neuroblastoma Patients (on the Behalf of Turkish Pediatric Oncology Group)" Proceedings 2, no. 25: 1530. https://doi.org/10.3390/proceedings2251530
APA StyleAltun, Z., Baran, B., Aktaş, S., Yuan, H., & Olgun, N. (2018). Whole Exome Sequencing Analysis of Good and Bad Prognostic Neuroblastoma Patients (on the Behalf of Turkish Pediatric Oncology Group). Proceedings, 2(25), 1530. https://doi.org/10.3390/proceedings2251530